Company Filing History:
Years Active: 2022-2024
Title: Innovations by Katie C Coate in the Treatment of Exocrine Pancreatic Insufficiency
Introduction
Katie C Coate is an accomplished inventor based in Pelham, Alabama. She has made significant contributions to the field of medical treatments, particularly focusing on conditions related to exocrine pancreatic insufficiency. With a total of 2 patents, her work is paving the way for innovative therapies that address complex health issues.
Latest Patents
Katie's latest patents include groundbreaking methods and compositions for the treatment of exocrine pancreatic insufficiency. The first patent discusses the administration of fibroblast growth factor 21 (FGF21) or its derivatives to treat secretory disorders. This invention is particularly useful for conditions such as exocrine pancreatic insufficiency resulting from various causes, including cystic fibrosis, alcoholism, and pancreatitis. The second patent also focuses on the use of FGF21, emphasizing its role in increasing exocrine pancreatic secretion and addressing salivary flow disorders like Sjögren's syndrome.
Career Highlights
Katie C Coate is affiliated with the University of Texas System, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving patient outcomes through novel therapeutic approaches.
Collaborations
Katie has collaborated with notable colleagues in her field, including David John Mangelsdorf and Steven Anthony Kliewer. These partnerships enhance the scope and impact of her research, contributing to the development of effective treatments.
Conclusion
Katie C Coate's innovative work in the treatment of exocrine pancreatic insufficiency showcases her dedication to advancing medical science. Her patents reflect a significant step forward in addressing complex health challenges, and her collaborations further amplify the potential impact of her research.